If you made any changes in Pure, your changes will be visible here soon.

Personal profile

SNI Level

  • SNI 1

Fingerprint Dive into the research topics where Manuel Jonathan Fragoso Vazquez is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 18 Similar Profiles
Valproic Acid Medicine & Life Sciences
Histone Deacetylase Inhibitors Medicine & Life Sciences
Computer Simulation Medicine & Life Sciences
Rosales Medicine & Life Sciences
Oenothera Medicine & Life Sciences
Trinitrobenzenes Medicine & Life Sciences
HMGB1 Protein Medicine & Life Sciences
Glucosidases Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2014 2019

  • 18 Citations
  • 2 h-Index
  • 4 Article
  • 1 Erratum
  • 1 Scientific review

Synthesis and biological evaluation of novel chromonyl enaminones as α-glucosidase inhibitors

Mendieta-Moctezuma, A., Rugerio-Escalona, C., Villa-Ruano, N., Gutierrez, R. U., Jiménez-Montejo, F. E., Fragoso-Vázquez, M. J., Correa-Basurto, J., Cruz-López, M. C., Delgado, F. & Tamariz, J., 1 Jun 2019, In : Medicinal Chemistry Research. 28, 6, p. 831-848 18 p.

Research output: Contribution to journalArticle

Inhibitory Concentration 50
Antifungal Agents
Open Access
Sulfonic Acids
Computer Simulation
2 Citations (Scopus)

Docking and QSAR studies of aryl-valproic acid derivatives to identify antiproliferative agents targeting the HDAC8

Martínez-Pacheco, H., Ramírez-Galicia, G., Vergara-Arias, M., Gertsch, J., Fragoso-Vázquez, M. J., Méndez-Luna, D., Abujamra, A. L., Cristina, C. P. L., Cecilia, R. H. M., Mendoza-Lujambio, I. & Correa-Basurto, J., 1 Jan 2017, In : Anti-Cancer Agents in Medicinal Chemistry. p. 927-940 832 p.

Research output: Contribution to journalScientific review

Histone Deacetylases
Quantitative Structure-Activity Relationship
Valproic Acid
Histone Deacetylase Inhibitors
Lymphoid Tissue
13 Citations (Scopus)

N-(2-hydroxyphenyl)-2-propylpentanamide, a valproic acid aryl derivative designed in silico with improved anti-proliferative activity in HeLa, rhabdomyosarcoma and breast cancer cells

Prestegui-Martel, B., Bermúdez-Lugo, J. A., Chávez-Blanco, A., Dueñas-González, A., García-Sánchez, J. R., Pérez-González, O. A., Padilla-Martínez, I. I., Fragoso-Vázquez, M. J., Mendieta-Wejebe, J. E., Correa-Basurto, A. M., Méndez-Luna, D., Trujillo-Ferrara, J. & Correa-Basurto, J., 3 Nov 2016, In : Journal of Enzyme Inhibition and Medicinal Chemistry. p. 140-149 125 p.

Research output: Contribution to journalArticle

Valproic Acid
Computer Simulation
Breast Neoplasms
Triple Negative Breast Neoplasms